根治性前列腺切除术后放疗的严重晚期毒性风险——一项全国性研究
基于瑞典前列腺癌数据库(PCBaSe)1997至2016年间全部40962例根治性前列腺切除术(RP)男性,按1:2匹配创建术后放疗组2789例与未暴露组5578例。术后放疗组10年泌尿系操作累积发生率17.8% vs 未暴露组10.5%(RR 1.74,95%CI 1.47至2.05),血尿6.0% vs 1.2%(RR 6.50,95%CI 4.31至10.10),膀胱癌2.4% vs 1.1%(RR 2.71,95%CI 1.72至4.33);肠道毒性、其他第二恶性肿瘤及非前列腺癌死亡率两组相似。
要点
- 术后放疗组10年泌尿系操作发生率为17.8%,未暴露组为10.5%(RR 1.74,95%CI 1.47至2.05)。
- 术后放疗组10年血尿发生率为6.0%,未暴露组为1.2%(RR 6.50,95%CI 4.31至10.10)。
- 术后放疗组10年膀胱癌发生率为2.4%,未暴露组为1.1%(RR 2.71,95%CI 1.72至4.33)。
核心结论
- 根治性前列腺切除术后放疗的严重晚期毒性主要累及膀胱,且可在放疗后多年出现。
研究设计与样本
- 全国性队列研究,纳入瑞典前列腺癌数据库(PCBaSe)1997至2016年间全部40962例接受根治性前列腺切除术的男性。
- 按1:2匹配创建术后放疗暴露组2789例与未暴露组5578例,两组年龄、合并症及手术年份可比。
- 计算泌尿系或肠道需住院治疗的症状与干预、第二恶性肿瘤及非前列腺癌死亡率的累积发生率和率比。
主要发现
- 术后放疗组 vs 未暴露组10年泌尿系操作累积发生率为17.8% vs 10.5%(差值7.3%,95%CI 4.4至10.3;RR 1.74,95%CI 1.47至2.05)。
- 术后放疗组 vs 未暴露组10年血尿累积发生率为6.0% vs 1.2%(差值4.8%,95%CI 3.1至6.5;RR 6.50,95%CI 4.31至10.10)。
- 术后放疗组 vs 未暴露组10年膀胱癌累积发生率为2.4% vs 1.1%(差值1.4%,95%CI 0.4至2.3;RR 2.71,95%CI 1.72至4.33)。
- 两组在肠道毒性、其他第二恶性肿瘤及非前列腺癌死亡率方面相似。
- 对术前肿瘤危险因素的调整未明显影响率比。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the long-term risks of severe late toxicities for radiation therapy (RT) following radical prostatectomy (RP) in an unselected nationwide cohort, as severe side-effects are rare but may occur years later. PATIENTS AND METHODS: The study population comprised all men undergoing RP between 1997 and 2016 in the Prostate Cancer database Sweden (PCBaSe) (n = 40 962). By (1:2) matching, two cohorts were created: 2789 men exposed to postoperative RT and 5578 unexposed men with comparable age, comorbidities, and year of surgery. Cumulative incidences and rate ratios were calculated for the following outcomes: symptoms and interventions of the urinary or intestinal tract demanding inpatient care, secondary malignancies, and non-prostate cancer mortality. RESULTS: The largest differences were seen for late toxicities affecting the urinary tract. The 10-year cumulative incidences among those exposed to postoperative RT vs the RP-only group were: 17.8% vs 10.5% for procedures of the urinary tract (difference 7.3%, 95% confidence interval [CI] 4.4 to 10.3; relative risk [RR] 1.74, 95% CI 1.47 to 2.05); 6.0% vs 1.2% for haematuria (difference 4.8%, 95% CI 3.1 to 6.5; RR 6.50, 95% CI 4.31 to 10.10); and 2.4% vs 1.1% for bladder cancer (difference 1.4%, 95% CI 0.4 to 2.3; RR 2.71, 95% CI 1.72 to 4.33). The groups were similar regarding intestinal toxicity, other secondary malignancies, and non-prostate cancer mortality. Adjustments for preoperative tumour risk factors did not importantly affect the rate ratios. CONCLUSION: Severe late toxicity after postoperative RT following RP predominately affects the bladder and can appear many years after RT.
引用
- Braide K, Kindblom J, Thellenberg Karlsson C, et al. Risk of severe late toxicity after radiotherapy following radical prostatectomy - a nationwide study. BJU Int. 2022. PMID: 35523728. doi:10.1111/bju.15769
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。